{"id":120973,"date":"2025-12-30T14:52:16","date_gmt":"2025-12-30T14:52:16","guid":{"rendered":"https:\/\/www.europesays.com\/se\/120973\/"},"modified":"2025-12-30T14:52:16","modified_gmt":"2025-12-30T14:52:16","slug":"beslut-om-als-medicin-omprovas-svt-nyheter","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/se\/120973\/","title":{"rendered":"Beslut om ALS-medicin ompr\u00f6vas | SVT Nyheter"},"content":{"rendered":"<p>Svenska ALS-patienter stoppas fr\u00e5n att ta l\u00e4kemedlet Tofersen. Efter nya r\u00f6n ska dock beslutet ompr\u00f6vas. <\/p>\n<p>Tofersen ges i flera europeiska l\u00e4nder till patienter med den \u00e4rftliga SOD1- mutationen. I Sverige har regionernas expertr\u00e5d, NT-r\u00e5det, avr\u00e5tt regionerna fr\u00e5n att erbjuda behandlingen p\u00e5 grund av att man tycker det saknats evidens f\u00f6r hur effektiv behandlingen \u00e4r. <\/p>\n<p>Kostnaden f\u00f6r Tofersen \u00e4r 3,5 miljoner kronor per patient per \u00e5r. <\/p>\n<p>\u2013 Det \u00e4r ett v\u00e4ldigt dyrt l\u00e4kemedel med en h\u00f6g os\u00e4kerhet kring effekten, s\u00e4ger r\u00e5dets ordf\u00f6rande \u00c5sa Derolf till SVT.<\/p>\n","protected":false},"excerpt":{"rendered":"Svenska ALS-patienter stoppas fr\u00e5n att ta l\u00e4kemedlet Tofersen. Efter nya r\u00f6n ska dock beslutet ompr\u00f6vas. Tofersen ges i&hellip;\n","protected":false},"author":2,"featured_media":793,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[69],"tags":[113,112,34,31,33,32,30],"class_list":{"0":"post-120973","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-halsa","8":"tag-halsa","9":"tag-health","10":"tag-se","11":"tag-svenska","12":"tag-sverige","13":"tag-sweden","14":"tag-swedish"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@se\/115809087856135409","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/120973","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/comments?post=120973"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/120973\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media\/793"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media?parent=120973"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/categories?post=120973"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/tags?post=120973"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}